Antifungal drug resistance of oral fungi

Masakazu Niimi1, Norman A Firth, Richard D Cannon

  • 1Department of Oral Sciences, School of Dentistry, University of Otago, 310 Great King Street, Dunedin, 9016, New Zealand.

Odontology
|February 16, 2010
PubMed

Insights

Oral fungi cause disease, with candidiasis being common. Antifungal resistance in biofilms, often due to efflux pumps, complicates treatment, suggesting combined therapies are needed.

Area of Science:

  • Microbiology
  • Oral Health
  • Mycology

Background:

  • Fungi are a minor part of the oral microbiota but can cause significant oral disease.
  • Oral candidiasis is the most common oral fungal infection, presenting in various forms.
  • Current treatments for oral candidiasis include polyenes (e.g., nystatin) and azoles (e.g., fluconazole).

Purpose of the Study:

  • To review the mechanisms of antifungal resistance in oral fungi.
  • To explore the role of biofilms in antifungal resistance.
  • To discuss strategies for improving the treatment and prevention of oral fungal diseases.

Main Methods:

  • Review of existing literature on oral fungal microbiota, oral candidiasis, antifungal agents, and resistance mechanisms.
  • Analysis of factors contributing to antifungal resistance in fungal biofilms.
  • Discussion of therapeutic approaches combining antifungal drugs with biofilm disruption.

Main Results:

  • Resistance to polyenes is rare, but some Candida species exhibit innate azole resistance, and Candida albicans can acquire it.
  • Energy-dependent drug efflux is a primary mechanism for high-level azole resistance in fungi.
  • Oral fungal biofilms exhibit increased antifungal resistance due to efflux pumps, matrix permeability, and cellular stress responses.

Conclusions:

  • Multispecies oral biofilms significantly contribute to antifungal resistance.
  • Combined therapies targeting both fungal cells and biofilm structures are crucial for effective treatment and prevention of oral fungal diseases.
  • Further research into biofilm-disrupting agents and combination therapies is warranted.

Related Concept Videos

Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Candidiasis01:20

Candidiasis

Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...
Fungal Group Zygomycota01:29

Fungal Group Zygomycota

Zygomycota, previously classified as a distinct fungal group, are primarily terrestrial, saprophytic molds that play a crucial role as decomposers. Recent phylogenetic studies have revealed that these fungi are now divided into two major clades — Mucoromycota, which includes many symbiotic species, and Zoopagomycota, which primarily consists of parasitic and pathogenic fungi. These groups exhibit distinct ecological roles and reproductive strategies while sharing key structural and...
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...